Welcome to the Nephrology specialty hub, where you will find a wide range of resources related to nephrology and kidney disease. Take an in-depth look into chronic kidney disease and learn information about diagnosis and treatment of renal diseases.
More on what you will find in this hub:
- Our sponsored, interactive Chronic Kidney Disease Learning Zone with expert interviews, quiz-based patient case studies, a patient case animation, and more
- Nephrology related news and insights, drugs, guidelines, clinical trials and events
- What your peers are searching for
Utilise these resources to prevent worsening of renal disease, or progression to kidney failure and the need for dialysis. Help your patients in effectively treating and managing symptoms of renal disorders.
Related news and insights
Bristol Myers Squibb announced that Opdivo (nivolumab) plus Yervoy (ipilimumab) continued to demonstrate durable, long-term survival in the Phase III CheckMate -214 trial, with a five-year survival rate of 48% in patients with previously untreated advanced or metastatic renal cell carcinoma (RCC).
Travere Therapeutics, Inc. and Vifor Pharma announced the companies have entered into a joint collaboration and licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand.
It provides comprehensive up-to-date information on the understanding and care of patients with chronic kidney disease(CKD), especially in terms of their metabolic and nutritional milieu for the practicing clinician and allied health care workers.